We are excited to welcome our newest member.
For decades, LICORbio has pioneered fluorescence imaging technologies to meet the needs of the global scientific community. Committed to “Impacting Lives through Science,” Lambda Instruments Corporation was founded in 1971 and became LI-COR Biosciences in 1978. In 2021, co-founders Bill and Elaine Biggs were inducted into the Nebraska Business Hall of Fame. LI-COR Biosciences was then acquired by Battery Ventures, a global technology-focused investment firm, and its biotechnology division was rebranded to LICORbio.
LICORbio’s Odyssey® Imaging Systems have delivered industry-leading sensitivity and scanning speed for over 25 years, and LICORbio’s products are cited in over 130,000 peer-reviewed publications. Imaging probes and agents conjugated to LICORbio® IRDye® Infrared Dyes have propelled more than 20 Phase I and Phase II clinical trials worldwide.
From innovative protocols and imaging systems to powerful analysis software, affordable reagents, and world-class scientific support, LICORbio continues to empower researchers around the globe to answer difficult questions, make groundbreaking discoveries, and improve countless facets of human health. Visit licorbio.com to learn more.